Cargando…
Chimeric antigen receptor (CAR) T-cell treatment for mantle cell lymphoma (MCL)
Mantle cell lymphoma (MCL) is a rare B-cell malignancy that remains challenging to treat with high rates of relapse. Frontline strategies range from intensive chemotherapy followed by consolidation with autologous stem cell transplant (ASCT), to less-intensive therapies including combination regimen...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
SAGE Publications
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8882938/ https://www.ncbi.nlm.nih.gov/pubmed/35237395 http://dx.doi.org/10.1177/20406207221080738 |